132 related articles for article (PubMed ID: 6169957)
1. The pharmacological basis for the use of labetalol in the treatment of hypertension.
Prichard BN; Richards DA
J Cardiovasc Pharmacol; 1981; 3 Suppl 1():S24-9. PubMed ID: 6169957
[No Abstract] [Full Text] [Related]
2. Labetalol, an alpha- and beta-adrenergic blocking drug in the treatment of hypertension.
Rosei EA; Fraser R; Morton JJ; Brown JJ; Lever AF; Robertson JI; Trust PM
Am Heart J; 1977 Jan; 93(1):124-5. PubMed ID: 12654
[No Abstract] [Full Text] [Related]
3. Labetolol--combined alpha and beta blockade for hypertension.
Raftery EB
Scott Med J; 1978 Oct; 23(4):279-80. PubMed ID: 31683
[No Abstract] [Full Text] [Related]
4. Labetalol for hypertension.
Med Lett Drugs Ther; 1984 Sep; 26(670):83-5. PubMed ID: 6147747
[No Abstract] [Full Text] [Related]
5. Labetalol: an alpha- and beta-blocker.
Conner CS
Drug Intell Clin Pharm; 1983; 17(7-8):543-4. PubMed ID: 6135593
[TBL] [Abstract][Full Text] [Related]
6. Combined alpha- and beta-adrenergic blockade in the treatment of hypertension: myth or reality? Workshop held in Corsendonck (Belgium) on February 28, 1981.
J Cardiovasc Pharmacol; 1981; 3 Suppl 1():S1-74. PubMed ID: 6169955
[No Abstract] [Full Text] [Related]
7. Labetalol: an alpha- and beta-adrenoceptor blocking drug.
Michelson EL; Frishman WH
Ann Intern Med; 1983 Oct; 99(4):553-5. PubMed ID: 6137987
[TBL] [Abstract][Full Text] [Related]
8. [Hypertensive emergencies: clinical evaluation of the use of a new drug: labetalol hydrochloride].
Rossano P; Saffiotti O; Mayer MC; Blasich M; Rossano G; Bellotti P
Minerva Cardioangiol; 1980 May; 28(5):309-14. PubMed ID: 6111048
[No Abstract] [Full Text] [Related]
9. Labetalol therapy in patients with systemic hypertension and angina pectoris: effects of combined alpha and beta adrenoceptor blockade.
Frishman WH; Strom JA; Kirschner M; Poland M; Klein N; Halprin S; LeJemtel TH; Kram M; Sonnenblick EH
Am J Cardiol; 1981 Nov; 48(5):917-28. PubMed ID: 6118060
[No Abstract] [Full Text] [Related]
10. Antihypertensive effect of labetalol, a new alpha- and beta-adrenergic blocking agent.
Hansson L; Hänel B
Int J Clin Pharmacol Biopharm; 1976 Oct; 14(3):195-8. PubMed ID: 12115
[TBL] [Abstract][Full Text] [Related]
11. The pharmacology of labetalol, an alpha- and beta-adrenoceptor blocking agent.
Blakeley AG; Summers RJ
Gen Pharmacol; 1978; 9(6):399-402. PubMed ID: 32121
[No Abstract] [Full Text] [Related]
12. Combined alpha- and beta-receptor inhibition in the treatment of hypertension.
Prichard BN
Drugs; 1984; 28 Suppl 2():51-68. PubMed ID: 6151891
[TBL] [Abstract][Full Text] [Related]
13. Interdose control of beta-blockade and arterial blood pressure during chronic oral labetalol treatment.
Sanders GL; Murray A; Rawlins MD
Br J Clin Pharmacol; 1979; 8(Suppl 2):125S-127S. PubMed ID: 43163
[TBL] [Abstract][Full Text] [Related]
14. Labetalol, a new alpha- and beta-adrenoreceptor blocking agent, in hypertension.
Hansson L; Hänel B
Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):763-4. PubMed ID: 10952
[TBL] [Abstract][Full Text] [Related]
15. Labetalol in hypertension.
Lancet; 1977 Apr; 1(8017):890-1. PubMed ID: 67294
[No Abstract] [Full Text] [Related]
16. Hemodynamic effects of labetalol, an alpha and beta adrenergic blocking agent, in hypertensive subjects.
Mehta J; Cohn JN
Circulation; 1977 Feb; 55(2):370-5. PubMed ID: 12880
[TBL] [Abstract][Full Text] [Related]
17. Labetalol (AH5158), a competitive alpha- and beta-receptor blocking drug, in the management of hypertension.
Rosei EA; Brown JJ; Fraser R; Lever AF; Morton JJ; Robertson JI; Trust PM
Aust N Z J Med; 1976 Aug; 6(3 Suppl):83-8. PubMed ID: 14627
[TBL] [Abstract][Full Text] [Related]
18. Labetalol in the treatment of severe essential hypertension: relationship between arterial blood pressure, plasma catecholamines, plasma renin activity, plasma aldosterone and body weight.
Kornerup HJ; Pedersen EB; Christensen NJ; Pedersen A; Pedersen G
Acta Med Scand Suppl; 1979; 625():59-64. PubMed ID: 34981
[No Abstract] [Full Text] [Related]
19. Labetalol in hypertension.
Lancet; 1977 May; 1(8022):1147-8. PubMed ID: 68239
[No Abstract] [Full Text] [Related]
20. Sympathetic nervous activity and the pressor effect of noradrenaline under chronic alpha-beta-adrenoceptor blockade with labetalol in hypertension.
Zschiedrich H; Neurohr W; Lüth JB; Philipp T; Distler A
Klin Wochenschr; 1983 Jul; 61(13):661-7. PubMed ID: 6310204
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
